Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Apr 13, 2007 12:26pm
210 Views
Post# 12602388

RE: Re: Webcast............Dr. Cruz Said

RE: Re: Webcast............Dr. Cruz Said Like they say winer.......you snooze you lose. Phase1's for Gastrin alone were released months ago maybe years ago......they have been quoting that G1 has no Nausea for months and months ....... maybe years. It's aknown fact that its not Gastrin that causes nausea and headaches its the other Factors !! Dr. Cruz said nothing about the GLP1-INT Data except that its just about complete. I would suggest you get your facts straight......... Have you read Dr. Andre Uddins Presentation from the mARRS Seminar last year? If you had you would see that there will be no release of Data for GLP1-INT until the Patents are Secured. I have a pdf of the presentation if you want it. Good Luck
Bullboard Posts